Equities

Kneat.com Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Kneat.com Inc

Actions
  • Price (EUR)2.56
  • Today's Change0.00 / 0.00%
  • Shares traded170.00
  • 1 Year change-44.35%
  • Beta1.2769
Data delayed at least 15 minutes, as of Feb 11 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. The Company designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product, Kneat Gx, is a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, and cold chain validation.

  • Revenue in CAD (TTM)60.00m
  • Net income in CAD-1.19m
  • Incorporated2013
  • Employees297.00
  • Location
    Kneat.com IncUnit 7,Castletroy Park Business Centre,LIMERICK V94 5F68IrelandIRL
  • Phone+353 61203826
  • Websitehttps://kneat.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.